Pharmed Limited, established in 1946 and headquartered in Bangalore, India, is recognized as one of the fastest-growing pharmaceutical companies in the country. The company focuses on manufacturing a wide range of evidence-based pharmaceutical and nutraceutical products, primarily targeting specialized therapy areas such as women's health, orthopedic health, pain management, and general healthcare. Its commitment to quality and innovation has led to the introduction of several "first-time in India" brands
Checking authentication...
Checking authentication...
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 359.6 | 425.99 | 436 | - |
| Cost of Material Consumed | - | - | - | - |
| Gross Margins | - | - | - | - |
| Change in Inventory | - | - | - | - |
| Employee Benefit Expenses | 97.79 | 129.79 | - | - |
| Other Expenses | - | - | - | - |
| EBITDA | - | - | - | - |
| OPM | - | - | - | - |
| Other Income | 9.45 | 9.98 | 9.98 | - |
| Finance Cost | 0.36 | 0.3 | 0.36 | - |
| D&A | 2.32 | 3.27 | 3.27 | - |
| EBIT | 55.02 | 43.1 | 43.1 | - |
| EBIT Margins | - | - | - | - |
| PBT | 55.02 | 43.1 | 43.1 | - |
| PBT Margins | - | - | - | - |
| Tax (2021) | - | - | - | - |
| PAT | 42.3 | 33 | 9.36 | |
| NPM | - | - | - | - |
| EPS | - | - | - | - |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | - | - | - | - |
| Net Profit Margin | 0.1176 | 0.1208 | 0.0777 | - |
| Earning Per Share (Diluted) | ₹76.54 | ₹98.27 | ₹76.54 | - |
| Promoters | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Suneet Aurora | Chairman and Managing Director | 30+ | in |
| Yogesh Saran Aurora | Board Member | 40+ | - |
| Dr. Jagdish Chinnappa | Independent Director | 20+ | - |
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
The current market price of Pharmed Limited unlisted shares is ₹820 per share.
The minimum lot size is ₹100.0 shares, and trades must be placed in multiples of this.
The shares have traded as high as ₹1000 and as low as ₹580 over the past year.
The shares are held in - depositories under ISIN INE0EEI01017.
Pharmed Limited Shares's market capitalization is approximately 396 crore.
The company has P/E ratio of -, P/B ratio of -, Debt-to-Equity ratio of -, ROE of -%.
The book value of Pharmed Limited Shares is ₹- per share.
The face value of Pharmed Limited unlisted shares is ₹2.0 per share.
Pharmed Limited Shares has 4306200 shares outstanding.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
Discover a variety of unlisted shares beyond the popular picks. Stay updated with real-time pricing, emerging opportunities, and market trends to diversify your portfolio and make confident investment decisions.
.avif&w=256&q=75)
₹62
.avif&w=256&q=75)
₹248
₹975
₹118
₹38
₹0
